Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4

References

• Adali O, Arinç E. (1990). Electrophoretic, spectral, catalytic and immunochemical properties of highly purified cytochrome P-450 from sheep lung. Int J Biochem 22:1433–1444.
   Google Scholar
• Arinç E, Philpot M. (1976). Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J Biol Chem 251:3213–3220.
   PubMed Web of Science ®Google Scholar
• Arinç E, Rzepecki LM, Strittmatter P. (1987). Topography of the C terminus of cytochrome b5 tightly bound to dimyristoylphosphatidylcholine vesicles. J Biol Chem 262:15563–15567.
   Google Scholar
• Arinç E. (1991). Essential features of NADH dependent cytochrome b5 reductase and cytochrome b5 of liver and lung microsomes. In: Arinç E, Schenkman JB, Hodgson E, eds. Molecular Aspects of Monooxygenases and Bioactivation of Toxic Compounds. New York: Plenum Press, 149–171.
   Google Scholar
• Arinç E, Güray T, Saplakoglu U, Adali O. (1992). Purification and characterization of two forms of soluble NADH cytochrome b5 reductases from human erythrocytes. Comp Biochem Physiol, B 101:235–242.
   PubMedGoogle Scholar
• Arinç E, Pasha RP, Adali O, Basaran N. (1994). Stimulatory effects of lung cytochrome b5 on benzphetamine N-demethylation in a reconstituted system containing lung cytochrome P450LgM2. Int J Biochem 26:1033–1042.
   Google Scholar
• Arinç E, Adali O, Pasha RP, Basaran N. (1995). Different influences of two fractions of lung cytochrome b5 on reconstituted lung benzphetamine N-demethylase system. Int J Biochem Cell Biol 27:1095–1105.
   Google Scholar
• Arinç E, Cakir D. (1999). Simultaneous purification and characterization of cytochrome b5 reductase and cytochrome b5 from sheep liver. Int J Biochem Cell Biol 31:345–362.
   Google Scholar
• Arinç E. (2010). The role of polymorphic cytochrome P450 enzymes in drug design, development and drug interactions with a special emphasis on phenotyping. J Mol Catal B: Enzy 64:120–122.
   Web of Science ®Google Scholar
• Barham HM, Stratford IJ. (1996). Enzymology of the reduction of the novel fused pyrazine mono-n-oxide bioreductive drug, RB90740 roles for P450 reductase and cytochrome b5 reductase. Biochem Pharmacol 51:829–837.
   PubMed Web of Science ®Google Scholar
• Belcourt MF, Hodnick WF, Rockwell S, Sartorelli AC. (1998). The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells. J Biol Chem 273:8875–8881.
   PubMedGoogle Scholar
• Bonfils C, Balny C, Maurel P. (1981). Direct evidence for electron transfer from ferrous cytochrome b5 to the oxyferrous intermediate of liver microsomal cytochrome P-450 LM2. J Biol Chem 256:9457–9465.
   PubMed Web of Science ®Google Scholar
• Çelik H. (2008). Enzyme-catalyzed reductive activation of anticancer drugs idarubicin and mitomycin C. Ph.D. Dissertation, Middle East Technical University, Ankara, Turkey.
   Google Scholar
• Çelik H, Arinç E. (2008). Bioreduction of idarubicin and formation of ROS responsible for DNA cleavage by NADPH-cytochrome P450 reductase and its potential role in the antitumor effect. J Pharm Pharm Sci 11:68–82.
   Google Scholar
• Çelik H, Arinç E. (2010). Evaluation of the protective effects of quercetin, rutin, naringenin, resveratrol and trolox against idarubicin-induced DNA damage. J Pharm Pharm Sci 13:231–241.
   PubMed Web of Science ®Google Scholar
• Çelik H, Kosar M. (2012). Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: structure-activity relationships. Chem Biol Interact 197:103–109.
   PubMed Web of Science ®Google Scholar
• Cerletti P, Siliprandi N. (1958). Pure crystalline flavine adenine dinucleotide. Arch Biochem Biophys 76:214–224.
   Google Scholar
• Crivellari D, Lombardi D, Spazzapan S, Veronesi A, Toffoli G. (2004). New oral drugs in older patients: a review of idarubicin in elderly patients. Crit Rev Oncol Hematol 49:153–163.
   PubMed Web of Science ®Google Scholar
• Doll DC, Weiss RB, Issell BF. (1985). Mitomycin: ten years after approval for marketing. J Clin Oncol 3:276–286.
   PubMed Web of Science ®Google Scholar
• Doroshow JH. (2006). Anthracyclines and anthracenediones. In: Chabner BA, Longo DL, eds. Cancer Chemotherapy and Biotherapy: Principles and Practices. Philadelphia: Lippincott Williams and Wilkins, 415–450.
   Google Scholar
• Fang C, Gu J, Xie F, Behr M, Yang W, Abel ED, Ding X. (2008). Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity. Drug Metab Dispos 36:1722–1728.
   PubMed Web of Science ®Google Scholar
• Fisher GR, Gutierrez PL. (1991). Free radical formation and DNA strand breakage during metabolism of diaziquone by NAD(P)H quinone-acceptor oxidoreductase (DT-diaphorase) and NADPH cytochrome c reductase. Free Radic Biol Med 11:597–607.
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727–741.
   PubMed Web of Science ®Google Scholar
• Goeptar AR, te Koppele JM, van Maanen JM, Zoetemelk CE, Vermeulen NP. (1992). One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450. Biochem Pharmacol 43:343–352.
   PubMed Web of Science ®Google Scholar
• Goeptar AR, Te Koppele JM, Lamme EK, Piqué JM, Vermeulen NP. (1993). Cytochrome P450 2B1-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes. Mol Pharmacol 44:1267–1277.
   PubMed Web of Science ®Google Scholar
• Goeptar AR, Groot EJ, Scheerens H, Commandeur JN, Vermeulen NP. (1994). Cytotoxicity of mitomycin C and adriamycin in freshly isolated rat hepatocytes: the role of cytochrome P450. Cancer Res 54:2411–2418.
   PubMed Web of Science ®Google Scholar
• Guray T, Arinç E. (1990). Purification of NADH-cytochrome b5 reductase from sheep lung and its electrophoretic, spectral and some other properties. Int J Biochem 22:1029–1037.
   PubMedGoogle Scholar
• Hodnick WF, Sartorelli AC. (1993). Reductive activation of mitomycin C by NADH:cytochrome b5 reductase. Cancer Res 53:4907–4912.
   PubMedGoogle Scholar
• Hodnick WF, Sartorelli AC. (1994). The pH-dependent reduction of Adriamycin catalysed by NADH:cytochrome b5 reductase. Cancer Lett 84:149–154.
   Google Scholar
• Holtz KM, Rockwell S, Tomasz M, Sartorelli AC. (2003). Nuclear overexpression of NADH:cytochrome b5 reductase activity increases the cytotoxicity of mitomycin C (MC) and the total number of MC-DNA adducts in Chinese hamster ovary cells. J Biol Chem 278:5029–5034.
   PubMedGoogle Scholar
• Iscan MY, Arinç E. (1988). Comparison of highly purified sheep liver and lung NADPH-cytochrome P-450 reductases by the analysis of kinetic and catalytic properties. Int J Biochem 20:1189–1196.
   PubMedGoogle Scholar
• Jounaidi Y, Chen CS, Veal GJ, Waxman DJ. (2006). Enhanced antitumor activity of P450 prodrug-based gene therapy using the low Km cyclophosphamide 4-hydroxylase P450 2B11. Mol Cancer Ther 5:541–555.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Lu AY, Levin W. (1974). The resolution and reconstitution of the liver microsomal hydroxylation system. Biochim Biophys Acta 344:205–240.
   PubMed Web of Science ®Google Scholar
• Lu H, Chen CS, Waxman DJ. (2009). Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer. Cancer Gene Ther 16:393–404.
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Yubisui T, Akaike T. (1999). Free radical generation from heterocyclic amines by cytochrome b5 reductase in the presence of NADH. Cancer Lett 143:117–121.
   PubMed Web of Science ®Google Scholar
• Mahmutoglu I, Kappus H. (1988). Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5. Mol Pharmacol 34:578–583.
   PubMedGoogle Scholar
• Marín A, López de Cerain A, Hamilton E, Lewis AD, Martinez-Peñuela JM, Idoate MA, Bello J. (1997). DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours. Br J Cancer 76:923–929.
   PubMed Web of Science ®Google Scholar
• Masters BSS, Williams CH, Kamin H. (1967). The preparation and properties of microsomal TPNH-cytochrome c reductase from pig liver. Methods Enzymol 10:565–573.
   Google Scholar
• McCarthy HO, Yakkundi A, McErlane V, Hughes CM, Keilty G, Murray M, Patterson LH, Hirst DG, McKeown SR, Robson T. (2003). Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N. Cancer Gene Ther 10:40–48.
   PubMed Web of Science ®Google Scholar
• McManus ME, Huggett A, Burgess W, Robson R, Birkett DJ. (1989). Immunochemical and catalytical characterization of the human liver NADPH-cytochrome P450 reductase. Clin Exp Pharmacol Physiol 16:121–134.
   Google Scholar
• Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. (2004). Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229.
   PubMed Web of Science ®Google Scholar
• Nishibayashi H, Sato R. (1968). Preparation of hepatic microsomal particles containing P-450 as the sole heme constituent and absolute spectra of P-450. J Biochem 63:766–779.
   Google Scholar
• Omura T, Sato R. (1964). The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem 239:2379–2385.
   PubMed Web of Science ®Google Scholar
• Ozols J, Korza G, Heinemann FS, Hediger MA, Strittmatter P. (1985). Complete amino acid sequence of steer liver microsomal NADH-cytochrome b5 reductase. J Biol Chem 260:11953–11961.
   PubMedGoogle Scholar
• Powis G. (1989). Free radical formation by antitumor quinones. Free Radic Biol Med 6:63–101.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Antona C, Ingelman-Sundberg M. (2006). Cytochrome P450 pharmacogenetics and cancer. Oncogene 25:1679–1691.
   PubMed Web of Science ®Google Scholar
• Rooseboom M, Commandeur JN, Vermeulen NP. (2004). Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol Rev 56:53–102.
   PubMed Web of Science ®Google Scholar
• Roy P, Waxman DJ. (2006). Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer. Toxicol In Vitro 20:176–186.
   PubMed Web of Science ®Google Scholar
• Sen A, Arinc E. (1998). Purification and characterization of cytochrome P450 reductase from liver microsomes of feral leaping mullet (Liza saliens). J Biochem Mol Toxicol 12:103–113.
   Google Scholar
• Seow HA, Penketh PG, Baumann RP, Sartorelli AC. (2004). Bioactivation and resistance to mitomycin C. Meth Enzymol 382:221–233.
   PubMed Web of Science ®Google Scholar
• Shen A, Kasper CB. (1993). Protein and gene structure and regulation of NADPH-cytochrome P450 reductase. In: Schenkman JB, Greim H, eds. Handbook of Experimental Pharmacology. New York: Springer-Verlag Press, 35–59.
   Google Scholar
• Strittmatter P, Velick SF. (1956). The isolation and properties of microsomal cytochrome. J Biol Chem 221:253–264.
   PubMed Web of Science ®Google Scholar
• Strittmatter P, Velick SF. (1957). The purification and properties of microsomal cytochrome reductase. J Biol Chem 228:785–799.
   PubMed Web of Science ®Google Scholar
• Talakad JC, Shah MB, Walker GS, Xiang C, Halpert JR, Dalvie D. (2011). Comparison of in vitro metabolism of ticlopidine by human cytochrome P450 2B6 and rabbit cytochrome P450 2B4. Drug Metab Dispos 39:539–550.
   PubMed Web of Science ®Google Scholar
• Vromans RM, van de Straat R, Groeneveld M, Vermeulen NP. (1990). One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase. Xenobiotica 20:967–978.
   PubMed Web of Science ®Google Scholar
• Yubisui T, Miyata T, Iwanaga S, Tamura M, Takeshita M. (1986). Complete amino acid sequence of NADH-cytochrome b5 reductase purified from human erythrocytes. J Biochem 99:407–422.
   Google Scholar